Artesunate mefloquine

DRUG2 trials

Sponsors

University of Bamenda, University of Oxford

Conditions

Drug Resistant Malaria Due to Plasmodium FalciparumMalaria

Phase 3

Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa

CompletedNCT02974348

University of BamendaDrug Resistant Malaria Due to Plasmodium Falciparum

Start: 2013-01-31End: 2014-10-31Updated: 2016-11-29

Developing Triple Artemisinin Combination Therapies Trial in Africa

RecruitingPACTR202104845356660

University of OxfordMalaria

Start: 2020-09-01Target: 3240Updated: 2026-01-27

Related Papers

Genetic diversity of Plasmodium falciparum and genetic profile in children affected by uncomplicated malaria in Cameroon

Malaria Journal2020-03-1866 citations